CLB 📈 Core Laboratories - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: NL0000200384

CLB: Laboratory, Analytical, Testing, Services, Reservoir, Enhancement, Products

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas. Web URL: https://www.corelab.com

Additional Sources for CLB Stock

CLB Stock Overview

Market Cap in USD 955m
Sector Energy
Industry Oil & Gas Equipment & Services
GiC Sub-Industry Oil & Gas Equipment & Services
IPO / Inception 1995-09-20

CLB Stock Ratings

Growth 5y -45.7%
Fundamental 30.3%
Dividend 13.3%
Rel. Strength Industry -488
Analysts 2.71/5
Fair Price Momentum 14.25 USD
Fair Price DCF 24.08 USD

CLB Dividends

Dividend Yield 12m 0.24%
Yield on Cost 5y 0.09%
Annual Growth 5y -55.13%
Payout Consistency 85.9%

CLB Growth Ratios

Growth Correlation 3m 35.8%
Growth Correlation 12m 72.2%
Growth Correlation 5y -37.2%
CAGR 5y -18.28%
CAGR/Mean DD 5y -0.36
Sharpe Ratio 12m -0.08
Alpha -36.02
Beta 1.14
Volatility 45.01%
Current Volume 1101.2k
Average Volume 20d 324.9k
What is the price of CLB stocks?
As of December 21, 2024, the stock is trading at USD 16.85 with a total of 1,101,233 shares traded.
Over the past week, the price has changed by -13.32%, over one month by -17.04%, over three months by -9.26% and over the past year by -8.31%.
Is Core Laboratories a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Core Laboratories is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.33 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLB as of December 2024 is 14.25. This means that CLB is currently overvalued and has a potential downside of -15.43%.
Is CLB a buy, sell or hold?
Core Laboratories has received a consensus analysts rating of 2.71. Therefor, it is recommend to hold CLB.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 4
  • Sell: 1
  • Strong Sell: 1
What are the forecast for CLB stock price target?
According to ValueRays Forecast Model, CLB Core Laboratories will be worth about 15.8 in December 2025. The stock is currently trading at 16.85. This means that the stock has a potential downside of -6.41%.
Issuer Forecast Upside
Wallstreet Target Price 20 18.7%
Analysts Target Price 23.3 38%
ValueRay Target Price 15.8 -6.4%